Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.279270304187925e-73,87.82828282828282,14567.28057147188,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.5703578742600552e-70,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.7982998943864485e-39,31.032880258899677,2754.844843794886,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'COX11', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",3.875645353725231e-37,0,0,46
3,Nonalcoholic fatty liver disease WP4396,8.299580039446107e-19,8.38686067597387,349.16943122961885,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",7.663278903088571e-17,0,0,37
4,Oxidative phosphorylation WP623,3.622266566699169e-18,20.79129831859941,834.9667252082327,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA2', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MG', 'ATP5MF', 'ATP5ME']",2.5084195974391745e-16,0,0,23
5,Mitochondrial CIV Assembly WP4922,1.8275329823991106e-17,34.16726959517657,1316.84004115909,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",1.0124532722491072e-15,0,0,19
6,Mitochondrial complex I assembly model OXPHOS system WP4324,7.714892270453818e-17,21.29393468118196,790.0218853086966,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'TMEM126B']",3.561708598192845e-15,0,0,21
7,Mitochondrial complex III assembly WP4921,7.045562538099932e-07,27.818873668188736,394.07375361212416,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",2.7880297472195443e-05,0,0,7
8,Cellular Proteostasis WP4918,0.0001720382068116886,31.654545454545456,274.3750783150579,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.005956822910854718,0,0,4
9,Pyrimidine metabolism WP4022,0.0002425673960642067,4.173630861226573,34.74226724852031,"['NT5C', 'POLE4', 'POLD4', 'POLR3GL', 'POLE3', 'NME2', 'TK1', 'POLR2I', 'POLR2K', 'NME1', 'POLR2L']",0.007465685412198362,0,0,11
10,Nucleotide Excision Repair WP4753,0.003658911142739719,4.754407294832827,26.675028492517587,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'MNAT1', 'GTF2H5']",0.1013518386538902,0,0,6
11,DNA Mismatch Repair WP531,0.005852752310430801,7.029629629629629,36.13822401716957,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.1448349198194122,0,0,4
12,mRNA Processing WP411,0.006274436959685728,2.9770992366412212,15.097678587456228,"['LSM7', 'SNRPD1', 'CELF1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SNRPF', 'SRSF9', 'LSM2']",0.1448349198194122,0,0,9
13,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.018577635740649984,6.76961314026367,26.982302400069198,"['EIF2S2', 'EIF3D', 'EIF1']",0.39040872708231933,0,0,3
14,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.019731849022211086,15.779456193353475,61.94259055403586,"['ELOB', 'ELOC']",0.39040872708231933,0,0,2
15,Base Excision Repair WP4752,0.028456773234772543,3.9515151515151516,14.064900816693402,"['POLE4', 'POLD4', 'APEX1', 'POLE3']",0.5255017457354663,0,0,4
16,DNA Repair Pathways Full Network WP4946,0.03592112053891153,2.2630662020905925,7.527930945956954,"['POLE4', 'POLD4', 'CENPX', 'RFC2', 'APEX1', 'POLE3', 'MNAT1', 'GTF2H5']",0.5484214431431906,0,0,8
17,Nanomaterial induced apoptosis WP2507,0.038746577804922716,4.737367624810893,15.39982177427393,"['ENDOG', 'BAX', 'CYCS']",0.5484214431431906,0,0,3
18,Eukaryotic Transcription Initiation WP405,0.03911722212690871,3.5117845117845117,11.382369429337457,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2K']",0.5484214431431906,0,0,4
19,Proteasome Degradation WP183,0.03957255563670514,2.9283988085202046,9.457613721421785,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMB10']",0.5484214431431906,0,0,5
20,Translation Factors WP107,0.0444345841872932,2.8235421634511164,8.791768240769372,"['EEF1B2', 'EIF1AY', 'EIF2S2', 'EIF3D', 'EIF1']",0.5484214431431906,0,0,5
21,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.04553679852813496,7.888217522658611,24.368553880424987,"['COX8A', 'CYP2C8']",0.5484214431431906,0,0,2
22,Dual hijack model of Vif in HIV infection WP3300,0.04553679852813496,7.888217522658611,24.368553880424987,"['ELOB', 'ELOC']",0.5484214431431906,0,0,2
23,Nanoparticle triggered regulated necrosis WP2513,0.04553679852813496,7.888217522658611,24.368553880424987,"['TRADD', 'FTL']",0.5484214431431906,0,0,2
24,Copper homeostasis WP3286,0.05175989633686426,3.16,9.357201235719712,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.5973954702213082,0,0,4
25,Mitochondrial CII Assembly WP4920,0.059754993395309874,inf,inf,['SDHAF1'],0.6620853268200334,0,0,1
26,Sleep regulation WP3591,0.0663662045559627,2.8721763085399448,7.79097159067014,"['CACNA1I', 'CRH', 'BTBD9', 'HCRTR1']",0.7070553331539103,0,0,4
27,Gastric Cancer Network 2 WP2363,0.08878646147672566,3.156732223903177,7.644093691824618,"['AHCTF1', 'S100A6', 'COL9A3']",0.9108833270019633,0,0,3
28,Selenium Micronutrient Network WP15,0.10860258845386904,1.9351777185038148,4.296210717374446,"['SELENOM', 'PRDX5', 'SELENOS', 'SELENOW', 'TXN', 'SELENOH']",0.9993285687722023,0,0,6
29,Serotonin and anxiety WP3947,0.1167142525479928,3.9425981873111784,8.468805847836665,"['POMC', 'CRH']",0.9993285687722023,0,0,2
30,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.1167142525479928,3.9425981873111784,8.468805847836665,"['RRAS2', 'HRAS']",0.9993285687722023,0,0,2
31,ERK Pathway in Huntington's Disease WP3853,0.13722201155256836,3.5041960389392415,6.959876983073957,"['NTRK2', 'HRAS']",0.9993285687722023,0,0,2
32,Cytosolic DNA-sensing pathway WP4655,0.1427363350433885,2.1046464646464647,4.0972334728701885,"['POLR3GL', 'TRADD', 'POLR2K', 'POLR2L']",0.9993285687722023,0,0,4
33,Heme Biosynthesis WP561,0.1687808662312076,7.877828054298643,14.015869727050987,['HMBS'],0.9993285687722023,0,0,1
34,p38 MAPK Signaling Pathway WP400,0.17019809945238984,2.2535119948130538,3.990501529409659,"['TRADD', 'DDIT3', 'HRAS']",0.9993285687722023,0,0,3
35,Overview of nanoparticle effects WP3287,0.18019687978165352,2.866520186761879,4.912370691177777,"['COL4A1', 'BAX']",0.9993285687722023,0,0,2
36,Splicing factor NOVA regulated synaptic proteins WP4148,0.1853859634095264,2.150873332416449,3.6248998182527776,"['KCNQ2', 'GRIK2', 'ANK3']",0.9993285687722023,0,0,3
37,MED and Pseudoachondroplasia genes WP4789,0.21846389521054635,5.251382604323781,7.988059343568638,['COL9A3'],0.9993285687722023,0,0,1
38,Mevalonate pathway WP3963,0.21846389521054635,5.251382604323781,7.988059343568638,['PMVK'],0.9993285687722023,0,0,1
39,TP53 network WP1742,0.22481592700439107,2.4250522891006274,3.6193258260732866,"['SUMO1', 'BAX']",0.9993285687722023,0,0,2
40,Ciliary landscape WP4352,0.22768419360715436,1.3501398363783685,1.9979311593012594,"['COPS6', 'IFT22', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'TMED1', 'SNRPB2', 'COX6C', 'LSM4']",0.9993285687722023,0,0,10
41,Benzo(a)pyrene metabolism WP696,0.2651815102305853,3.93815987933635,5.227280061066213,['AKR1A1'],0.9993285687722023,0,0,1
42,Valproic acid pathway WP3871,0.2651815102305853,3.93815987933635,5.227280061066213,['HSD17B10'],0.9993285687722023,0,0,1
43,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.2651815102305853,3.93815987933635,5.227280061066213,['PMVK'],0.9993285687722023,0,0,1
44,Peroxiredoxin 2 induced ovarian failure WP4873,0.2651815102305853,3.93815987933635,5.227280061066213,['BAX'],0.9993285687722023,0,0,1
45,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.27012194265072614,2.1013091641490433,2.7503652843445323,"['H2AFJ', 'H2AFZ']",0.9993285687722023,0,0,2
46,Parkinson's disease pathway WP2371,0.29278887730684516,1.9697885196374623,2.419498103298054,"['CYCS', 'PARK7']",0.9993285687722023,0,0,2
47,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.29278887730684516,1.9697885196374623,2.419498103298054,"['GRB10', 'HRAS']",0.9993285687722023,0,0,2
48,Serotonin and anxiety-related events WP3944,0.30911045422107103,3.1502262443438913,3.698543941799242,['CRH'],0.9993285687722023,0,0,1
49,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.30911045422107103,3.1502262443438913,3.698543941799242,['CYP2C8'],0.9993285687722023,0,0,1
50,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.30911045422107103,3.1502262443438913,3.698543941799242,['VEGFB'],0.9993285687722023,0,0,1
51,TNF-alpha signaling pathway WP231,0.3116633213640882,1.3831429864494316,1.612512038835995,"['TRADD', 'BAX', 'TXN', 'BTRC', 'HRAS']",0.9993285687722023,0,0,5
52,Type 2 papillary renal cell carcinoma WP4241,0.31535701916449627,1.8537408921272436,2.139309468550763,"['ELOB', 'ELOC']",0.9993285687722023,0,0,2
53,Glycosylation and related congenital defects WP4521,0.31535701916449627,1.8537408921272436,2.139309468550763,"['DPM2', 'DPM3']",0.9993285687722023,0,0,2
54,GABA receptor Signaling WP4159,0.3377573192455882,1.7505874454514938,1.9001359851320492,"['GABRB3', 'SLC32A1']",0.9993285687722023,0,0,2
55,7q11.23 copy number variation syndrome WP4932,0.3476545788706992,1.3136064744562468,1.3878855106335306,"['RFC2', 'ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9993285687722023,0,0,5
56,TCA cycle in senescence WP5050,0.3504169516996661,2.624937154348919,2.7525918983163318,['ME1'],0.9993285687722023,0,0,1
57,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.3504169516996661,2.624937154348919,2.7525918983163318,['SST'],0.9993285687722023,0,0,1
58,Codeine and Morphine Metabolism WP1604,0.3504169516996661,2.624937154348919,2.7525918983163318,['CYP2C8'],0.9993285687722023,0,0,1
59,Homologous recombination WP186,0.3504169516996661,2.624937154348919,2.7525918983163318,['POLD4'],0.9993285687722023,0,0,1
60,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3504169516996661,2.624937154348919,2.7525918983163318,['RPS6'],0.9993285687722023,0,0,1
61,Insulin signaling in adipocytes (normal condition) WP3634,0.3504169516996661,2.624937154348919,2.7525918983163318,['RPS6'],0.9993285687722023,0,0,1
62,Purine metabolism WP4792,0.3504169516996661,2.624937154348919,2.7525918983163318,['APRT'],0.9993285687722023,0,0,1
63,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.35992930964851166,1.6582922563205598,1.6945220101460665,"['GABRB3', 'NTRK2']",0.9993285687722023,0,0,2
64,MAPK Cascade WP422,0.38182032696007073,1.575226586102719,1.5166362369032407,"['RASA3', 'HRAS']",0.9993285687722023,0,0,2
65,Modulators of TCR signaling and T cell activation WP5072,0.38197785772354637,1.3901397170063183,1.337860226838764,"['NDUFB10', 'ELOB', 'RNF7']",0.9993285687722023,0,0,3
66,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3892573335463273,2.2497306614953674,2.122653788742113,['DLL3'],0.9993285687722023,0,0,1
67,Biomarkers for pyrimidine metabolism disorders WP4584,0.3892573335463273,2.2497306614953674,2.122653788742113,['NT5C'],0.9993285687722023,0,0,1
68,Iron metabolism in placenta WP2007,0.3892573335463273,2.2497306614953674,2.122653788742113,['FTH1'],0.9993285687722023,0,0,1
69,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3892573335463273,2.2497306614953674,2.122653788742113,['BAX'],0.9993285687722023,0,0,1
70,BDNF-TrkB Signaling WP3676,0.40338479771140157,1.5000719320961013,1.3618618139365777,"['NTRK2', 'HRAS']",0.9993285687722023,0,0,2
71,CAMKK2  Pathway WP4874,0.40338479771140157,1.5000719320961013,1.3618618139365777,"['CHRM3', 'FIS1']",0.9993285687722023,0,0,2
72,MET in type 1 papillary renal cell carcinoma WP4205,0.41480440113158484,1.312657589510842,1.1550706731739584,"['RPL11', 'HRAS', 'PAK4']",0.9993285687722023,0,0,3
73,IL-18 signaling pathway WP4754,0.42381694334685455,1.1097471680234312,0.952666511811028,"['NRN1', 'RASA3', 'NACA', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'RPS11', 'RND2']",0.9993285687722023,0,0,10
74,Tamoxifen metabolism WP691,0.42577862462308164,1.9683257918552035,1.6806268860051723,['CYP2C8'],0.9993285687722023,0,0,1
75,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.42577862462308164,1.9683257918552035,1.6806268860051723,['IDH3B'],0.9993285687722023,0,0,1
76,Pyrimidine metabolism and related diseases WP4225,0.42577862462308164,1.9683257918552035,1.6806268860051723,['NT5C'],0.9993285687722023,0,0,1
77,RalA downstream regulated genes WP2290,0.42577862462308164,1.9683257918552035,1.6806268860051723,['HRAS'],0.9993285687722023,0,0,1
78,Bladder cancer WP2828,0.4453833667252233,1.3693681859976357,1.1075721974051362,"['DAPK1', 'HRAS']",0.9993285687722023,0,0,2
79,Prader-Willi and Angelman Syndrome WP3998,0.4470527274636904,1.2433314754359424,1.0009797286860955,"['GABRB3', 'POMC', 'FEZ1']",0.9993285687722023,0,0,3
80,Genes targeted by miRNAs in adipocytes WP1992,0.4601190971958234,1.7494553376906319,1.358049548143629,['TMSB4X'],0.9993285687722023,0,0,1
81,"GPCRs, Class B Secretin-like WP334",0.4601190971958234,1.7494553376906319,1.358049548143629,['ADGRL2'],0.9993285687722023,0,0,1
82,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4601190971958234,1.7494553376906319,1.358049548143629,['ANAPC11'],0.9993285687722023,0,0,1
83,Kit receptor signaling pathway WP304,0.46290990798406073,1.2113348074013732,0.9329977198213135,"['RPS6', 'GRB10', 'HRAS']",0.9993285687722023,0,0,3
84,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4749184831197621,1.038512571020311,0.7732890307036899,"['RPS6', 'FRS2', 'TXN', 'RPL10A', 'RPL7', 'CYP2C8', 'RPL18A', 'TMSB4X', 'GRB10', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9993285687722023,0,0,18
85,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.48580661076809434,1.1246753246753247,0.8119533387009625,"['RPS6', 'RRAS2', 'BAX', 'HRAS']",0.9993285687722023,0,0,4
86,Apoptosis Modulation by HSP70 WP384,0.4924087908900488,1.5743589743589743,1.1153483678295393,['CYCS'],0.9993285687722023,0,0,1
87,Fatty acid transporters WP5061,0.4924087908900488,1.5743589743589743,1.1153483678295393,['FABP6'],0.9993285687722023,0,0,1
88,Galanin receptor pathway WP4970,0.4924087908900488,1.5743589743589743,1.1153483678295393,['POMC'],0.9993285687722023,0,0,1
89,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.4924087908900488,1.5743589743589743,1.1153483678295393,['RPS6'],0.9993285687722023,0,0,1
90,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.4924087908900488,1.5743589743589743,1.1153483678295393,['BAX'],0.9993285687722023,0,0,1
91,MTHFR deficiency WP4288,0.4924087908900488,1.5743589743589743,1.1153483678295393,['CYCS'],0.9993285687722023,0,0,1
92,NOTCH1 regulation of endothelial cell calcification WP3413,0.4924087908900488,1.5743589743589743,1.1153483678295393,['DLL3'],0.9993285687722023,0,0,1
93,Nucleotide metabolism WP404,0.4924087908900488,1.5743589743589743,1.1153483678295393,['NME2'],0.9993285687722023,0,0,1
94,Purine metabolism and related disorders WP4224,0.4924087908900488,1.5743589743589743,1.1153483678295393,['APRT'],0.9993285687722023,0,0,1
95,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4940047924815149,1.152023910556806,0.8124188516170752,"['APEX1', 'RPS6', 'HRAS']",0.9993285687722023,0,0,3
96,Regulation of Actin Cytoskeleton WP51,0.4946496400820215,1.0735009671179885,0.7556433046097601,"['FGF17', 'CHRM3', 'TMSB4X', 'BRK1', 'RRAS2', 'PAK4']",0.9993285687722023,0,0,6
97,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.49886158451749846,1.1048378522062732,0.7683336393373288,"['POMC', 'RPS6', 'FRS2', 'HRAS']",0.9993285687722023,0,0,4
98,IL-2 signaling pathway WP49,0.5051317030815096,1.2110155705321868,0.8270462332521088,"['RPS6', 'HRAS']",0.9993285687722023,0,0,2
99,Interleukin-11 Signaling Pathway WP2332,0.5051317030815096,1.2110155705321868,0.8270462332521088,"['RPS6', 'HRAS']",0.9993285687722023,0,0,2
100,Transcriptional cascade regulating adipogenesis WP4211,0.5227700022849615,1.4310983134512547,0.928229940421444,['DDIT3'],0.9993285687722023,0,0,1
101,Cholesterol Biosynthesis Pathway WP197,0.5227700022849615,1.4310983134512547,0.928229940421444,['PMVK'],0.9993285687722023,0,0,1
102,Methionine De Novo and Salvage Pathway WP3580,0.5227700022849615,1.4310983134512547,0.928229940421444,['TXN'],0.9993285687722023,0,0,1
103,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5241004541304638,1.1660512476222447,0.7533529528362211,"['NTRK2', 'HRAS']",0.9993285687722023,0,0,2
104,DNA Replication WP466,0.5241004541304638,1.1660512476222447,0.7533529528362211,"['POLD4', 'RFC2']",0.9993285687722023,0,0,2
105,Ferroptosis WP4313,0.5241004541304638,1.1660512476222447,0.7533529528362211,"['FTH1', 'FTL']",0.9993285687722023,0,0,2
106,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5358645428246624,1.0264305537201004,0.6403632002556878,"['GABRB3', 'NTRK2', 'RPS6', 'FRS2', 'EIF2S2', 'HRAS']",0.9993285687722023,0,0,6
107,Sphingolipid Metabolism (general overview) WP4725,0.5513177452737635,1.3117144293614882,0.7810524418833283,['CERS6'],0.9993285687722023,0,0,1
108,Sphingolipid Metabolism (integrated pathway) WP4726,0.5513177452737635,1.3117144293614882,0.7810524418833283,['CERS6'],0.9993285687722023,0,0,1
109,Type II diabetes mellitus WP1584,0.5513177452737635,1.3117144293614882,0.7810524418833283,['SURF1'],0.9993285687722023,0,0,1
110,Hypertrophy Model WP516,0.5513177452737635,1.3117144293614882,0.7810524418833283,['IFRD1'],0.9993285687722023,0,0,1
111,Intraflagellar transport proteins binding to dynein WP4532,0.5513177452737635,1.3117144293614882,0.7810524418833283,['IFT22'],0.9993285687722023,0,0,1
112,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5513177452737635,1.3117144293614882,0.7810524418833283,['SCO2'],0.9993285687722023,0,0,1
113,Neural Crest Cell Migration in Cancer WP4565,0.5605413285399842,1.0854255651630378,0.6283010892790613,"['NTRK2', 'PAK4']",0.9993285687722023,0,0,2
114,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5605413285399842,1.0854255651630378,0.6283010892790613,"['NDUFA13', 'COPS6']",0.9993285687722023,0,0,2
115,Alzheimer's disease WP2059,0.5675097443650539,1.0263105965927777,0.5814022425724777,"['ATP5MD', 'CYCS', 'HSD17B10']",0.9993285687722023,0,0,3
116,Apoptosis Modulation and Signaling WP1772,0.5738570807974203,0.9990379990379991,0.5548406306332477,"['ENDOG', 'TRADD', 'CYCS', 'BAX']",0.9993285687722023,0,0,4
117,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5779991912408222,1.0491440080563947,0.5751227099568778,"['PPP1R14B', 'DDIT3']",0.9993285687722023,0,0,2
118,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5781601842105801,1.2106972966701472,0.6633462710578912,['HRAS'],0.9993285687722023,0,0,1
119,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5781601842105801,1.2106972966701472,0.6633462710578912,['CD63'],0.9993285687722023,0,0,1
120,Hippo-Merlin Signaling Dysregulation WP4541,0.5797446824897944,0.9833080424886191,0.5360675626344137,"['NTRK2', 'ITGAE', 'HRAS', 'CDH8', 'PAK4']",0.9993285687722023,0,0,5
121,NRF2 pathway WP2884,0.5902742316619487,0.9710747672305589,0.5119195920677267,"['FTH1', 'ME1', 'TXN', 'SLC6A20', 'FTL']",0.9993285687722023,0,0,5
122,Acute viral myocarditis WP4298,0.5950126915416794,0.983358547655068,0.5105327582030248,"['ENDOG', 'CYCS', 'BAX']",0.9993285687722023,0,0,3
123,Non-small cell lung cancer WP4255,0.5950126915416794,0.983358547655068,0.5105327582030248,"['CYCS', 'BAX', 'HRAS']",0.9993285687722023,0,0,3
124,Circadian rhythm related genes WP3594,0.5992385090953031,0.9573290980080736,0.4902440009672956,"['KDM5A', 'CAVIN3', 'CRH', 'BTRC', 'RPS27A', 'BTBD9', 'HCRTR1']",0.9993285687722023,0,0,7
125,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6033990409793875,1.1241111829347123,0.5678745997910399,['BAX'],0.9993285687722023,0,0,1
126,miRNA targets in ECM and membrane receptors WP2911,0.6033990409793875,1.1241111829347123,0.5678745997910399,['COL4A1'],0.9993285687722023,0,0,1
127,Proteoglycan biosynthesis WP4784,0.6033990409793875,1.1241111829347123,0.5678745997910399,['EXT2'],0.9993285687722023,0,0,1
128,Leptin signaling pathway WP2034,0.6083302280488739,0.9631973818271635,0.4787451283450025,"['RPS6', 'BAX', 'HRAS']",0.9993285687722023,0,0,3
129,Genotoxicity pathway WP4286,0.6113732160231599,0.9833836858006042,0.48387165928124737,"['RPS27', 'TRIAP1']",0.9993285687722023,0,0,2
130,Ebstein-Barr virus LMP1 signaling WP262,0.6271299785379444,1.049069884364002,0.4894975371055578,['TRADD'],0.9993285687722023,0,0,1
131,Kallmann's Syndrome WP5074,0.6271299785379444,1.049069884364002,0.4894975371055578,['FRS2'],0.9993285687722023,0,0,1
132,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6271299785379444,1.049069884364002,0.4894975371055578,['BAX'],0.9993285687722023,0,0,1
133,p53 transcriptional gene network WP4963,0.6272892384983075,0.9534926302297904,0.4446589418463474,"['SIVA1', 'BAX']",0.9993285687722023,0,0,2
134,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6494429610683872,0.9834087481146304,0.4244788140988991,['RPS6'],0.9993285687722023,0,0,1
135,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6494429610683872,0.9834087481146304,0.4244788140988991,['HRAS'],0.9993285687722023,0,0,1
136,Metapathway biotransformation Phase I and II WP702,0.6502578695578454,0.9035808347722952,0.38888878726198134,"['GSTK1', 'CYP2C8', 'GSTO1', 'AKR1A1', 'HS6ST3']",0.9993285687722023,0,0,5
137,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6575922689836872,0.8988347000431592,0.37676471354252644,"['PSMC5', 'PSMD7']",0.9993285687722023,0,0,2
138,Apoptosis WP254,0.6586227159780242,0.890160705620415,0.37173504368440374,"['TRADD', 'CYCS', 'BAX']",0.9993285687722023,0,0,3
139,Nanoparticle-mediated activation of receptor signaling WP2643,0.6704225928796655,0.9254724514240085,0.3700474108506175,['HRAS'],0.9993285687722023,0,0,1
140,Prolactin Signaling Pathway WP2037,0.6704420125213161,0.87359220036981,0.34927794222123126,"['RPS6', 'PPIB', 'HRAS']",0.9993285687722023,0,0,3
141,Synaptic Vesicle Pathway WP2267,0.6719889094529606,0.87378314870762,0.34734054734113184,"['SLC32A1', 'PARK7']",0.9993285687722023,0,0,2
142,Canonical and non-canonical Notch signaling WP3845,0.6901484375794065,0.8739735210323446,0.32411183713546377,['DLL3'],0.9993285687722023,0,0,1
143,Unfolded protein response WP4925,0.6901484375794065,0.8739735210323446,0.32411183713546377,['DDIT3'],0.9993285687722023,0,0,1
144,Disruption of postsynaptic signaling by CNV WP4875,0.6901484375794065,0.8739735210323446,0.32411183713546377,['DLGAP1'],0.9993285687722023,0,0,1
145,Imatinib and Chronic Myeloid Leukemia WP3640,0.6901484375794065,0.8739735210323446,0.32411183713546377,['SKP2'],0.9993285687722023,0,0,1
146,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6901484375794065,0.8739735210323446,0.32411183713546377,['FTL'],0.9993285687722023,0,0,1
147,PDGFR-beta pathway WP3972,0.6901484375794065,0.8739735210323446,0.32411183713546377,['HRAS'],0.9993285687722023,0,0,1
148,Photodynamic therapy-induced unfolded protein response WP3613,0.6901484375794065,0.8739735210323446,0.32411183713546377,['DDIT3'],0.9993285687722023,0,0,1
149,Androgen receptor signaling pathway WP138,0.7040874752241433,0.8273747909865435,0.29028665944221027,"['SUMO1', 'BAG1', 'PARK7']",0.9993285687722023,0,0,3
150,Sphingolipid pathway WP1422,0.7086953177112317,0.8278955306819084,0.28506892041139054,['CERS6'],0.9993285687722023,0,0,1
151,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7086953177112317,0.8278955306819084,0.28506892041139054,['PPIB'],0.9993285687722023,0,0,1
152,Pregnane X receptor pathway WP2876,0.7086953177112317,0.8278955306819084,0.28506892041139054,['PSMC5'],0.9993285687722023,0,0,1
153,Ras signaling WP4223,0.7150979071732857,0.8415110725141121,0.28218879927396845,"['NTRK2', 'RASA3', 'RRAS2', 'RASAL2', 'HRAS', 'PAK4']",0.9993285687722023,0,0,6
154,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7247080421071825,0.7861027190332326,0.25311438907140044,"['IFI27L2', 'HRAS']",0.9993285687722023,0,0,2
155,Oncostatin M Signaling Pathway WP2374,0.7247080421071825,0.7861027190332326,0.25311438907140044,"['RPS6', 'HRAS']",0.9993285687722023,0,0,2
156,22q11.2 copy number variation syndrome WP4657,0.7250210996362035,0.7991743378035334,0.2569781218709741,"['RANBP1', 'MRPL40', 'PAK4']",0.9993285687722023,0,0,3
157,Thermogenesis WP4321,0.7250210996362035,0.7991743378035334,0.2569781218709741,"['RPS6', 'FRS2', 'HRAS']",0.9993285687722023,0,0,3
158,Fluoropyrimidine Activity WP1601,0.7261335970146099,0.7864253393665158,0.25167283048518496,['TK1'],0.9993285687722023,0,0,1
159,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7261335970146099,0.7864253393665158,0.25167283048518496,['SUPT4H1'],0.9993285687722023,0,0,1
160,SARS-CoV-2 mitochondrial interactions WP5038,0.7261335970146099,0.7864253393665158,0.25167283048518496,['NDUFB9'],0.9993285687722023,0,0,1
161,PPAR signaling pathway WP3942,0.7367149680906189,0.766855795446172,0.2343160150315107,"['FABP6', 'ME1']",0.9993285687722023,0,0,2
162,Aryl Hydrocarbon Receptor Pathway WP2873,0.742529445741515,0.7489046900811607,0.2229434978219552,['BAX'],0.9993285687722023,0,0,1
163,Cell migration and invasion through p75NTR WP4561,0.742529445741515,0.7489046900811607,0.2229434978219552,['NTRK2'],0.9993285687722023,0,0,1
164,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.742529445741515,0.7489046900811607,0.2229434978219552,['HRAS'],0.9993285687722023,0,0,1
165,Vitamin D-sensitive calcium signaling in depression WP4698,0.757945089986333,0.714795008912656,0.19810138856080517,['KCNQ2'],0.9993285687722023,0,0,1
166,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.757945089986333,0.714795008912656,0.19810138856080517,['DDIT3'],0.9993285687722023,0,0,1
167,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.757945089986333,0.714795008912656,0.19810138856080517,['BAX'],0.9993285687722023,0,0,1
168,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.757945089986333,0.714795008912656,0.19810138856080517,['BAX'],0.9993285687722023,0,0,1
169,DNA damage response WP707,0.7593916129228206,0.7310475655167569,0.20121183268039777,"['CYCS', 'BAX']",0.9993285687722023,0,0,2
170,MECP2 and Associated Rett Syndrome WP3584,0.7700831208083267,0.7143641856632793,0.1866325160817521,"['SST', 'RPS6']",0.9993285687722023,0,0,2
171,miRNA regulation of DNA damage response WP1530,0.7700831208083267,0.7143641856632793,0.1866325160817521,"['CYCS', 'BAX']",0.9993285687722023,0,0,2
172,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7724390469991375,0.6836513869761952,0.17652027634720638,['HRAS'],0.9993285687722023,0,0,1
173,Amyotrophic lateral sclerosis (ALS) WP2447,0.7724390469991375,0.6836513869761952,0.17652027634720638,['BAX'],0.9993285687722023,0,0,1
174,White fat cell differentiation WP4149,0.7724390469991375,0.6836513869761952,0.17652027634720638,['DDIT3'],0.9993285687722023,0,0,1
175,Endothelin Pathways WP2197,0.7724390469991375,0.6836513869761952,0.17652027634720638,['RIIAD1'],0.9993285687722023,0,0,1
176,PDGF Pathway WP2526,0.7724390469991375,0.6836513869761952,0.17652027634720638,['HRAS'],0.9993285687722023,0,0,1
177,Endometrial cancer WP4155,0.7803584067448354,0.6984222893588452,0.17321010295983644,"['BAX', 'HRAS']",0.9993285687722023,0,0,2
178,Melanoma WP4685,0.7803584067448354,0.6984222893588452,0.17321010295983644,"['BAX', 'HRAS']",0.9993285687722023,0,0,2
179,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7803584067448354,0.6984222893588452,0.17321010295983644,"['BAX', 'HRAS']",0.9993285687722023,0,0,2
180,Myometrial relaxation and contraction pathways WP289,0.781006957061957,0.7620401608792374,0.18835439723829914,"['RGS19', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9993285687722023,0,0,5
181,Heart Development WP1591,0.7860663451587165,0.6551030668677728,0.15769253303956088,['VEGFB'],0.9993285687722023,0,0,1
182,Integrin-mediated Cell Adhesion WP185,0.7892235119413701,0.7139320588639801,0.16899179713912657,"['ITGAE', 'HRAS', 'PAK4']",0.9993285687722023,0,0,3
183,Small cell lung cancer WP4658,0.7972980013821982,0.7032086165240364,0.15929557387170817,"['COL4A1', 'CYCS', 'BAX']",0.9993285687722023,0,0,3
184,Alpha 6 Beta 4 signaling pathway WP244,0.7988787323610222,0.6288386123680242,0.14120326988540102,['HRAS'],0.9993285687722023,0,0,1
185,Monoamine GPCRs WP58,0.7988787323610222,0.6288386123680242,0.14120326988540102,['CHRM3'],0.9993285687722023,0,0,1
186,Rett syndrome causing genes WP4312,0.7988787323610222,0.6288386123680242,0.14120326988540102,['GPS2'],0.9993285687722023,0,0,1
187,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7997063481710825,0.6685736324484155,0.14943334954867837,"['CYCS', 'BAX']",0.9993285687722023,0,0,2
188,Tryptophan metabolism WP465,0.8109248710825443,0.6045945005221023,0.1267108347306256,['HSD17B10'],0.9993285687722023,0,0,1
189,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8109248710825443,0.6045945005221023,0.1267108347306256,['HRAS'],0.9993285687722023,0,0,1
190,Notch Signaling WP268,0.8109248710825443,0.6045945005221023,0.1267108347306256,['DLL3'],0.9993285687722023,0,0,1
191,Fas ligand pathway and stress induction of heat shock proteins WP314,0.822250521866554,0.5821462488129154,0.11393193505151532,['CYCS'],0.9993285687722023,0,0,1
192,Integrated Cancer Pathway WP1971,0.822250521866554,0.5821462488129154,0.11393193505151532,['BAX'],0.9993285687722023,0,0,1
193,NO/cGMP/PKG mediated Neuroprotection WP4008,0.822250521866554,0.5821462488129154,0.11393193505151532,['CYCS'],0.9993285687722023,0,0,1
194,Oxidation by Cytochrome P450 WP43,0.822250521866554,0.5821462488129154,0.11393193505151532,['CYP2C8'],0.9993285687722023,0,0,1
195,Oxidative Damage WP3941,0.822250521866554,0.5821462488129154,0.11393193505151532,['CYCS'],0.9993285687722023,0,0,1
196,Regulation of Microtubule Cytoskeleton WP2038,0.822250521866554,0.5821462488129154,0.11393193505151532,['PARD6A'],0.9993285687722023,0,0,1
197,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8328987163265661,0.5613014436543848,0.10263017078654703,['BAX'],0.9993285687722023,0,0,1
198,IL-5 signaling pathway WP127,0.8328987163265661,0.5613014436543848,0.10263017078654703,['RPS6'],0.9993285687722023,0,0,1
199,Neural Crest Cell Migration during Development WP4564,0.8328987163265661,0.5613014436543848,0.10263017078654703,['PAK4'],0.9993285687722023,0,0,1
200,"GPCRs, Other WP117",0.8339175545515688,0.6158995320182453,0.11186012690073142,"['CHRM3', 'ADGRL2']",0.9993285687722023,0,0,2
201,Head and Neck Squamous Cell Carcinoma WP4674,0.8416037143528272,0.6039972112479666,0.10415691732489664,"['RPS6', 'HRAS']",0.9993285687722023,0,0,2
202,Aryl Hydrocarbon Receptor Netpath WP2586,0.8429099198325696,0.541894211265408,0.0926071105923914,['HRAS'],0.9993285687722023,0,0,1
203,Wnt Signaling Pathway WP363,0.8429099198325696,0.541894211265408,0.0926071105923914,['RYK'],0.9993285687722023,0,0,1
204,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8429099198325696,0.541894211265408,0.0926071105923914,['HRAS'],0.9993285687722023,0,0,1
205,Pre-implantation embryo WP3527,0.8429099198325696,0.541894211265408,0.0926071105923914,['DDIT3'],0.9993285687722023,0,0,1
206,Breast cancer pathway WP4262,0.8505700171758033,0.6604784688995216,0.1068974797321959,"['FGF17', 'BAX', 'HRAS', 'DLL3']",0.9993285687722023,0,0,4
207,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8523221840125367,0.5237807943690297,0.08369528583791276,['PAK4'],0.9993285687722023,0,0,1
208,Corticotropin-releasing hormone signaling pathway WP2355,0.8560158103091657,0.5815150497929954,0.09040607054086973,"['POMC', 'CRH']",0.9993285687722023,0,0,2
209,Exercise-induced Circadian Regulation WP410,0.861171290589154,0.5068359850143531,0.07575264425439449,['SUMO1'],0.9993285687722023,0,0,1
210,Prostaglandin Synthesis and Regulation WP98,0.861171290589154,0.5068359850143531,0.07575264425439449,['S100A6'],0.9993285687722023,0,0,1
211,Retinoblastoma gene in cancer WP2446,0.8627639325593782,0.5708871189233727,0.08427102715215726,"['H2AFZ', 'SKP2']",0.9993285687722023,0,0,2
212,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8694908867119505,0.49095022624434387,0.06865812558661466,['RPS6'],0.9993285687722023,0,0,1
213,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8694908867119505,0.49095022624434387,0.06865812558661466,['PMVK'],0.9993285687722023,0,0,1
214,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8694908867119505,0.49095022624434387,0.06865812558661466,['BAX'],0.9993285687722023,0,0,1
215,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8694908867119505,0.49095022624434387,0.06865812558661466,['TRADD'],0.9993285687722023,0,0,1
216,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.877312612139585,0.4760272407331231,0.062308107071312076,['RPS6'],0.9993285687722023,0,0,1
217,ErbB signaling pathway WP673,0.8813056017862095,0.5412022085633921,0.06838134966805409,"['HRAS', 'PAK4']",0.9993285687722023,0,0,2
218,TGF-beta Signaling Pathway WP366,0.8902605670786944,0.5737426663222759,0.0666924712528421,"['PARD6A', 'SUMO1', 'BTRC']",0.9993285687722023,0,0,3
219,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8915796825519561,0.44873949579831934,0.051497553361814656,['RNF7'],0.9993285687722023,0,0,1
220,TGF-beta Receptor Signaling WP560,0.8915796825519561,0.44873949579831934,0.051497553361814656,['HRAS'],0.9993285687722023,0,0,1
221,IL-3 signaling pathway WP286,0.8915796825519561,0.44873949579831934,0.051497553361814656,['HRAS'],0.9993285687722023,0,0,1
222,Interferon type I signaling pathways WP585,0.8915796825519561,0.44873949579831934,0.051497553361814656,['RPS6'],0.9993285687722023,0,0,1
223,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8915796825519561,0.44873949579831934,0.051497553361814656,['TRADD'],0.9993285687722023,0,0,1
224,Pathways in clear cell renal cell carcinoma WP4018,0.8923508643969054,0.5230614300100704,0.05957454082198751,"['ME1', 'GRB10']",0.9993285687722023,0,0,2
225,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9041898403710195,0.4244017773429538,0.04274402403891047,['HRAS'],0.9993285687722023,0,0,1
226,Netrin-UNC5B signaling pathway WP4747,0.9041898403710195,0.4244017773429538,0.04274402403891047,['DAPK1'],0.9993285687722023,0,0,1
227,Notch Signaling Pathway Netpath WP61,0.9041898403710195,0.4244017773429538,0.04274402403891047,['DLL3'],0.9993285687722023,0,0,1
228,EGF/EGFR signaling pathway WP437,0.908754982078585,0.5802469135802469,0.055517889962152615,"['NDUFA13', 'GRB10', 'NEDD8', 'HRAS']",0.9993285687722023,0,0,4
229,Complement system WP2806,0.9116323123479486,0.4901812688821752,0.04535085360998961,"['RPS19', 'TXN']",0.9993285687722023,0,0,2
230,Pancreatic adenocarcinoma pathway WP4263,0.9116323123479486,0.4901812688821752,0.04535085360998961,"['BAX', 'PAK4']",0.9993285687722023,0,0,2
231,Integrated breast cancer pathway WP1984,0.9152266849702196,0.5343143996699216,0.04733144029267086,"['TRADD', 'BAX', 'FAU']",0.9993285687722023,0,0,3
232,Pathways Regulating Hippo Signaling WP4540,0.9200122328740002,0.4752357410967683,0.03961960173941292,"['NTRK2', 'CDH8']",0.9993285687722023,0,0,2
233,Peptide GPCRs WP24,0.9204125777284589,0.39245852187028657,0.0325478628328233,['HCRTR1'],0.9993285687722023,0,0,1
234,Proximal tubule transport WP4917,0.9251858376368249,0.38284957510208584,0.029770634145708897,['SLC6A20'],0.9993285687722023,0,0,1
235,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9296732178617368,0.373698197227609,0.02725086972457376,['TMSB4X'],0.9993285687722023,0,0,1
236,MAPK Signaling Pathway WP382,0.9299877441674663,0.5977000367839235,0.043383382507809765,"['FGF17', 'CACNA1I', 'NTRK2', 'DDIT3', 'RRAS2', 'HRAS']",0.9993285687722023,0,0,6
237,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9319567557554801,0.5053438094773315,0.03561100457596366,"['COL4A1', 'HRAS', 'DLL3']",0.9993285687722023,0,0,3
238,Pathways affected in adenoid cystic carcinoma WP3651,0.9338918161361648,0.3649724648356659,0.024962173484985382,['HRAS'],0.9993285687722023,0,0,1
239,ESC Pluripotency Pathways WP3931,0.9345782042664769,0.44790677600345274,0.030305358986680592,"['FGF17', 'HRAS']",0.9993285687722023,0,0,2
240,Hepatitis B infection WP4666,0.9349150326587051,0.499919528760421,0.03364439830779766,"['CYCS', 'BAX', 'HRAS']",0.9993285687722023,0,0,3
241,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9415860120515235,0.34868443103737223,0.02098716898828745,['CTSV'],0.9993285687722023,0,0,1
242,Endochondral Ossification WP474,0.9415860120515235,0.34868443103737223,0.02098716898828745,['CTSV'],0.9993285687722023,0,0,1
243,Nuclear Receptors Meta-Pathway WP2882,0.9419154644068323,0.5976412073425323,0.03576269982596424,"['PSMC5', 'FTH1', 'ME1', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9993285687722023,0,0,7
244,Mesodermal commitment pathway WP2857,0.9430926012570116,0.4843177316468331,0.028376564607698305,"['EXT2', 'RPL38', 'AHDC1']",0.9993285687722023,0,0,3
245,Cell cycle WP179,0.9438145761986864,0.42937549145387577,0.024828876375212305,"['SKP2', 'ANAPC11']",0.9993285687722023,0,0,2
246,DNA damage response (only ATM dependent) WP710,0.9438145761986864,0.42937549145387577,0.024828876375212305,"['BAX', 'HRAS']",0.9993285687722023,0,0,2
247,G1 to S cell cycle control WP45,0.9450909392273176,0.34107154567512626,0.01926171680828724,['MNAT1'],0.9993285687722023,0,0,1
248,Gastrin signaling pathway WP4659,0.946607682401718,0.42353229362292805,0.02323944809735705,"['RPS6', 'HRAS']",0.9993285687722023,0,0,2
249,16p11.2 proximal deletion syndrome WP4949,0.9514833239231291,0.32679738562091504,0.016252653101917165,['TMEM219'],0.9993285687722023,0,0,1
250,AGE/RAGE pathway WP2324,0.9514833239231291,0.32679738562091504,0.016252653101917165,['CYCS'],0.9993285687722023,0,0,1
251,Calcium Regulation in the Cardiac Cell WP536,0.9525182412733566,0.464957085723701,0.02261831225920263,"['CHRM3', 'RGS19', 'RGS6']",0.9993285687722023,0,0,3
252,T-cell receptor (TCR) signaling pathway WP69,0.9597057179755686,0.3074852867240411,0.01264643484040424,['HRAS'],0.9993285687722023,0,0,1
253,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9597057179755686,0.3074852867240411,0.01264643484040424,['RYK'],0.9993285687722023,0,0,1
254,Endoderm differentiation WP2853,0.9627598580563413,0.38666965051657903,0.014674603094456881,"['AHDC1', 'NME1']",0.9993285687722023,0,0,2
255,Spinal Cord Injury WP2431,0.9646439805581914,0.3819173237049591,0.01374756388110818,"['COL4A1', 'APEX1']",0.9993285687722023,0,0,2
256,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9665362842133866,0.2903189765934864,0.009881424187457008,['RYK'],0.9993285687722023,0,0,1
257,Adipogenesis WP236,0.9681411479039926,0.372752121996835,0.012068740225215176,"['CELF1', 'DDIT3']",0.9993285687722023,0,0,2
258,G Protein Signaling Pathways WP35,0.9722103254661266,0.2749596464766743,0.007749218980932532,['HRAS'],0.9993285687722023,0,0,1
259,Glioblastoma signaling pathways WP2261,0.9722103254661266,0.2749596464766743,0.007749218980932532,['HRAS'],0.9993285687722023,0,0,1
260,Focal Adhesion WP306,0.9724974987132784,0.45613802256138025,0.012720674774784323,"['COL4A1', 'VEGFB', 'HRAS', 'PAK4']",0.9993285687722023,0,0,4
261,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9767463386828658,0.3477005706612957,0.008180801084641226,"['NTRK2', 'SST']",0.9993285687722023,0,0,2
262,Neural Crest Differentiation WP2064,0.9796130629196536,0.2526638446942052,0.005204273618280303,['DLL3'],0.9993285687722023,0,0,1
263,PI3K-Akt signaling pathway WP4172,0.9800822265438471,0.5119657569975918,0.010300139846448612,"['FGF17', 'NTRK2', 'COL4A1', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS']",0.9993285687722023,0,0,7
264,Senescence and Autophagy in Cancer WP615,0.9819896056300479,0.2447209653092006,0.0044476947860462215,['HRAS'],0.9993285687722023,0,0,1
265,Male infertility WP4673,0.9819896056300479,0.2447209653092006,0.0044476947860462215,['PEX10'],0.9993285687722023,0,0,1
266,B Cell Receptor Signaling Pathway WP23,0.9840894426524424,0.2372594725535902,0.003805283454042743,['HRAS'],0.9993285687722023,0,0,1
267,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9861732780053428,0.4672340425531915,0.006505393711634739,"['FGF17', 'COL4A1', 'RPS6', 'VEGFB', 'ITGAE', 'HRAS']",0.9993285687722023,0,0,6
268,Insulin Signaling WP481,0.9863391322062594,0.3126283987915408,0.004300214894075231,"['GRB10', 'HRAS']",0.9993285687722023,0,0,2
269,"GPCRs, Class A Rhodopsin-like WP455",0.9867250384120393,0.3659228441754917,0.004890142219974252,"['CHRM3', 'OR6A2', 'HCRTR1']",0.9993285687722023,0,0,3
270,Wnt signaling WP428,0.9867897221827344,0.2268782652414366,0.003017097430930342,['RYK'],0.9993285687722023,0,0,1
271,Fragile X Syndrome  WP4549,0.9867897221827344,0.2268782652414366,0.003017097430930342,['NTRK2'],0.9993285687722023,0,0,1
272,Osteoblast differentiation WP4787,0.9914421286130487,0.20584266095102008,0.0017691559667634635,['DLL3'],0.9993285687722023,0,0,1
273,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9933230056061891,0.19547511312217195,0.0013095630887317714,['HRAS'],0.9993285687722023,0,0,1
274,Ectoderm Differentiation WP2858,0.9961808660365792,0.17555544257460978,0.0006717533292444884,['CDH8'],0.9993285687722023,0,0,1
275,Chemokine signaling pathway WP3929,0.9966268576840677,0.17166393184492731,0.0005800256780998727,['HRAS'],0.9993285687722023,0,0,1
276,Vitamin D Receptor Pathway WP2877,0.9989633407542169,0.14175236528177704,0.00014702512073005593,['S100A6'],0.9993285687722023,0,0,1
277,Ciliopathies WP4803,0.9993285687722023,0.13318121462917842,8.945206027307604e-05,['CCDC28B'],0.9993285687722023,0,0,1
